These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 32631421

  • 1. Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression.
    Xia C, Liu C, He Z, Cai Y, Chen J.
    J Exp Clin Cancer Res; 2020 Jul 06; 39(1):127. PubMed ID: 32631421
    [Abstract] [Full Text] [Related]

  • 2. Vorinostat upregulates MICA via the PI3K/Akt pathway to enhance the ability of natural killer cells to kill tumor cells.
    Xia C, He Z, Cai Y, Liang S.
    Eur J Pharmacol; 2020 May 15; 875():173057. PubMed ID: 32135122
    [Abstract] [Full Text] [Related]

  • 3. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
    Shi X, Ran L, Liu Y, Zhong SH, Zhou PP, Liao MX, Fang W.
    Oncol Rep; 2018 Mar 15; 39(3):939-950. PubMed ID: 29328485
    [Abstract] [Full Text] [Related]

  • 4. Metformin induces apoptosis and inhibits migration by activating the AMPK/p53 axis and suppressing PI3K/AKT signaling in human cervical cancer cells.
    Chen YH, Yang SF, Yang CK, Tsai HD, Chen TH, Chou MC, Hsiao YH.
    Mol Med Rep; 2021 Jan 15; 23(1):. PubMed ID: 33236135
    [Abstract] [Full Text] [Related]

  • 5. Metformin, a first-line drug for type 2 diabetes mellitus, disrupts the MALAT1/miR-142-3p sponge to decrease invasion and migration in cervical cancer cells.
    Xia C, Liang S, He Z, Zhu X, Chen R, Chen J.
    Eur J Pharmacol; 2018 Jul 05; 830():59-67. PubMed ID: 29704494
    [Abstract] [Full Text] [Related]

  • 6. Natural killer T cell cytotoxic activity in cervical cancer is facilitated by the LINC00240/microRNA-124-3p/STAT3/MICA axis.
    Zhang Y, Li X, Zhang J, Liang H.
    Cancer Lett; 2020 Apr 01; 474():63-73. PubMed ID: 31904481
    [Abstract] [Full Text] [Related]

  • 7. FNDC5 inhibits malignant growth of human cervical cancer cells via restraining PI3K/AKT pathway.
    Li N, Wang XL, Ge R, Wang Y, Tian XL, Zhu GQ, Zhou B.
    J Cell Physiol; 2024 Jun 01; 239(6):e31267. PubMed ID: 38558303
    [Abstract] [Full Text] [Related]

  • 8. HPV-induced Nurr1 promotes cancer aggressiveness, self-renewal, and radioresistance via ERK and AKT signaling in cervical cancer.
    Wan PK, Leung TH, Siu MK, Mo XT, Tang HW, Chan KK, Cheung AN, Ngan HY.
    Cancer Lett; 2021 Jan 28; 497():14-27. PubMed ID: 33010383
    [Abstract] [Full Text] [Related]

  • 9. Oleanolic acid inhibits cell survival and proliferation of prostate cancer cells in vitro and in vivo through the PI3K/Akt pathway.
    Li X, Song Y, Zhang P, Zhu H, Chen L, Xiao Y, Xing Y.
    Tumour Biol; 2016 Jun 28; 37(6):7599-613. PubMed ID: 26687646
    [Abstract] [Full Text] [Related]

  • 10. iTRAQ-based quantitative proteomic analysis of the inhibition of cervical cancer cell invasion and migration by metformin.
    Xia C, Yang F, He Z, Cai Y.
    Biomed Pharmacother; 2020 Mar 28; 123():109762. PubMed ID: 31864213
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
    Ramírez-Moya J, Wert-Lamas L, Santisteban P.
    Oncogene; 2018 Jun 28; 37(25):3369-3383. PubMed ID: 29353884
    [Abstract] [Full Text] [Related]

  • 12. Metformin combined with nelfinavir induces SIRT3/mROS-dependent autophagy in human cervical cancer cells and xenograft in nude mice.
    Xia C, He Z, Liang S, Chen R, Xu W, Yang J, Xiao G, Jiang S.
    Eur J Pharmacol; 2019 Apr 05; 848():62-69. PubMed ID: 30695683
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of HOXC11 by artesunate induces ferroptosis and suppresses ovarian cancer progression through transcriptional regulation of the PROM2/PI3K/AKT pathway.
    Li J, Feng L, Yuan Y, He T, Zou X, Su B, Liu K, Yang X.
    World J Surg Oncol; 2024 Oct 08; 22(1):268. PubMed ID: 39380001
    [Abstract] [Full Text] [Related]

  • 14. LncRNA-XIST/microRNA-126 sponge mediates cell proliferation and glucose metabolism through the IRS1/PI3K/Akt pathway in glioma.
    Cheng Z, Luo C, Guo Z.
    J Cell Biochem; 2020 Mar 08; 121(3):2170-2183. PubMed ID: 31680298
    [Abstract] [Full Text] [Related]

  • 15. Up-regulation of long non-coding RNA MFI2 functions as an oncogenic role in cervical cancer progression.
    Qu B, Zhao AH, Nie XZ, Sui R, Du MM, Jiang L, Wang HL.
    Eur Rev Med Pharmacol Sci; 2019 Jun 08; 23(11):4680-4687. PubMed ID: 31210294
    [Abstract] [Full Text] [Related]

  • 16. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B, Feng Y, Sun Y, Ji D, Qian W, Zhang Z, Wang Q, Zhang Y, Zhang C, Sun Y.
    Oncol Rep; 2018 Oct 08; 40(4):1885-1896. PubMed ID: 30066935
    [Abstract] [Full Text] [Related]

  • 17. Metformin inhibits the proliferation of rheumatoid arthritis fibroblast-like synoviocytes through IGF-IR/PI3K/AKT/m-TOR pathway.
    Chen K, Lin ZW, He SM, Wang CQ, Yang JC, Lu Y, Xie XB, Li Q.
    Biomed Pharmacother; 2019 Jul 08; 115():108875. PubMed ID: 31028998
    [Abstract] [Full Text] [Related]

  • 18. Period circadian regulator 2 suppresses drug resistance to cisplatin by PI3K/AKT pathway and improves chronochemotherapeutic efficacy in cervical cancer.
    Wang Z, Li F, He S, Zhao L, Wang F.
    Gene; 2022 Jan 30; 809():146003. PubMed ID: 34648915
    [Abstract] [Full Text] [Related]

  • 19. Hsa_circ_CSPP1/MiR-361-5p/ITGB1 Regulates Proliferation and Migration of Cervical Cancer (CC) by Modulating the PI3K-Akt Signaling Pathway.
    Yang W, Xie T.
    Reprod Sci; 2020 Jan 30; 27(1):132-144. PubMed ID: 32046405
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C, Shan Z, Hong J, Yang L.
    Int J Oncol; 2017 Jul 30; 51(1):235-244. PubMed ID: 28534966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.